Area of research
Epidemiology · Clinical Psychology
Research interest
Research interests include Cancer research, Medicine, microRNA, Cervical cancer, Vaccination, and Metastasis.
Determinants of human papillomavirus vaccination decision-making in Japan: a scoping review exploring contextual, social, and adolescent-specific influences
Risk of <scp>COVID</scp>‐19 death for people with a pre‐existing cancer diagnosis prior to <scp>COVID</scp>‐19‐vaccination: A systematic review and meta‐analysis
Cervical screening during the COVID-19 pandemic: optimising recovery strategies
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors
Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
Overcoming barriers in HPV vaccination and screening programs
Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
Tracking the global spread of vaccine sentiments: The global response to Japan's suspension of its HPV vaccine recommendation